Germline mutations in CDKN2A are frequently identified among melanoma kindreds and are associated with increased atypical nevus counts. However, a clear relationship between pathogenic CDKN2A mutation carriage and other nevus phenotypes including counts of common acquired nevi has not yet been established. Using data from GenoMEL, we investigated the relationships between CDKN2A mutation carriage and 2-mm, 5-mm, and atypical nevus counts among blood-related members of melanoma families. Compared with individuals without a pathogenic mutation, those who carried one had an overall higher prevalence of atypical (odds ratio = 1.64; 95% confidence interval = 1.18–2.28) nevi but not 2-mm nevi (odds ratio = 1.06; 95% confidence interval = 0.92–1.2...
Background Carrying the cyclin-dependent kinase inhibitor 2A (CDKN2A) germline mutations is associat...
Non-invasive diagnostic tools are effective in the histomorphological study of melanocytic lesions. ...
Purpose: Carriers of CDKN2A mutations have high risks of melanoma and certain other cancers. In this...
Germline mutations in CDKN2A are frequently identified among melanoma kindreds and are associated wi...
Germline mutations in CDKN2A are frequently identified among melanoma kindreds and are associated wi...
Patients with a family history of melanoma are at increased risk of this tumor. Those family members...
Patients with a family history of melanoma are at increased risk of this tumor. Those family members...
Melanocytic nevi are the most potent risk factors for melanoma yet identified. Variation in the nevu...
Germ-line mutations of CDKN2A have been identified as strong risk factors for melanoma in studies of...
Dysplastic nevi (DN) is a strong risk factor for cutaneous malignant melanoma (CMM), and it frequent...
Dysplastic nevi (DN) is a strong risk factor for cutaneous malignant melanoma (CMM), and it frequent...
Germline mutations in CDKN2A gene predispose to melanoma with high but incomplete penetrance. Pene-t...
Background Carrying the cyclin-dependent kinase inhibitor 2A (CDKN2A) germline mutations is associat...
<p><b>Background</b> Carrying the cyclin-dependent kinase inhibitor 2A (CDKN2A) germline mutations i...
The strongest known epidemiologic risk factor for melanoma is a large number of melanocytic nevi (Sw...
Background Carrying the cyclin-dependent kinase inhibitor 2A (CDKN2A) germline mutations is associat...
Non-invasive diagnostic tools are effective in the histomorphological study of melanocytic lesions. ...
Purpose: Carriers of CDKN2A mutations have high risks of melanoma and certain other cancers. In this...
Germline mutations in CDKN2A are frequently identified among melanoma kindreds and are associated wi...
Germline mutations in CDKN2A are frequently identified among melanoma kindreds and are associated wi...
Patients with a family history of melanoma are at increased risk of this tumor. Those family members...
Patients with a family history of melanoma are at increased risk of this tumor. Those family members...
Melanocytic nevi are the most potent risk factors for melanoma yet identified. Variation in the nevu...
Germ-line mutations of CDKN2A have been identified as strong risk factors for melanoma in studies of...
Dysplastic nevi (DN) is a strong risk factor for cutaneous malignant melanoma (CMM), and it frequent...
Dysplastic nevi (DN) is a strong risk factor for cutaneous malignant melanoma (CMM), and it frequent...
Germline mutations in CDKN2A gene predispose to melanoma with high but incomplete penetrance. Pene-t...
Background Carrying the cyclin-dependent kinase inhibitor 2A (CDKN2A) germline mutations is associat...
<p><b>Background</b> Carrying the cyclin-dependent kinase inhibitor 2A (CDKN2A) germline mutations i...
The strongest known epidemiologic risk factor for melanoma is a large number of melanocytic nevi (Sw...
Background Carrying the cyclin-dependent kinase inhibitor 2A (CDKN2A) germline mutations is associat...
Non-invasive diagnostic tools are effective in the histomorphological study of melanocytic lesions. ...
Purpose: Carriers of CDKN2A mutations have high risks of melanoma and certain other cancers. In this...